Cooling Pillow for Atopic Dermatitis
- Conditions
- Atopic DermatitisEczema
- Registration Number
- NCT01132651
- Lead Sponsor
- Northwestern University
- Brief Summary
The purpose of this study is to see if using a cooling pillow at night will help sleep quality in people with atopic dermatitis (AD).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 9
- Diagnosis of AD by dermatologist
- AD located on the head and neck
- Investigator Global Assessment (IGA)score >3 at time of enrollment
- Able to read, write, and understand study materials
- Age 18 or older
- Concurrent non-AD skin disease on the head and neck
- Active skin infection on the head and neck, or conditions that may interfere with evaluation of the skin
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in Sleep Quality as Measured by a Change in Pittsburgh Sleep Quality Index (PSQI) Survey Score Baseline and at 2 weeks The PSQI is a clinical survey used to measure sleep quality. Seven components related to sleep quality are scored: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medications, and daytime dysfunction. Each component is scored on a scale of 0 to 3. A score of 0 is associated with better sleep quality and a score of 3 is associated with worse sleep quality. The seven component scores are summed to achieve a total PSQI score. The total PSQI score has a range of 0-21. A score of 0 is associated with better sleep quality and a score of 21 is associated with worse sleep quality.
Buysse,D.J., Reynolds,C.F., Monk,T.H., Berman,S.R., \& Kupfer,D.J. (1989). The Pittsburgh Sleep Quality Index (PSQI): A new instrument for psychiatric research and practice. Psychiatry Research, 28(2), 193-213.
- Secondary Outcome Measures
Name Time Method Change in Severity of Atopic Dermatitis (AD) as Measured by a Change in Investigator Global Assessment (IGA) Score Baseline and at 2 weeks The IGA score is an assessment of AD severity. It is an assessment of the patient's disease state at the time of examination and does not attempt a comparison with any of the patient's previous disease states. Possible scores range from 0 to 5. A score of 0 is associated with no evidence of AD and a score of 5 is associated with severe AD.
Trial Locations
- Locations (1)
Northwestern University Feinberg School of Medicine, Department of Dermatology
🇺🇸Chicago, Illinois, United States
Northwestern University Feinberg School of Medicine, Department of Dermatology🇺🇸Chicago, Illinois, United States